Cannabis Kills Some Oral Bacteria but Promotes Others, Potentially Worsening Gum Disease | Research

The takeaway

CBD killed several bacteria that cause gum disease at physiologically relevant doses, but other harmful oral bacteria were completely resistant, potentially explaining why cannabis users have higher rates of periodontitis.

Dentists, periodontists, cannabis users concerned about oral health, and microbiome researchers.

What the researchers found

Multiple oral bacteria were sensitive to physiological CBD concentrations, including A. actinomycetemcomitans, F. nucleatum, P. gingivalis, S. mutans, and T. forsythia. However, other pathobionts were resistant even at superphysiological CBD concentrations, including oral Treponema species, C. gracilis, and V. parvula. This selective killing may create microbial dysbiosis favoring resistant pathogens.

Why it matters

Cannabis users have higher rates of periodontal disease, and the mechanism has been unclear. This study provides a compelling explanation: cannabis selectively kills some oral bacteria while sparing others, creating an imbalanced oral microbiome that favors disease-causing species.

The numbers in context

CBD-sensitive: A. actinomycetemcomitans, F. nucleatum, multiple P. gingivalis strains, S. mutans, S. gordonii, T. forsythia. CBD-resistant (even at superphysiological doses): C. gracilis, C. durum, H. parainfluenzae, oral Treponema species, V. parvula. Antimicrobial peptoids rendered CBD toxic to normally resistant spirochetes.

How the study worked

Panel of oral bacteria tested for CBD susceptibility at physiological and superphysiological concentrations. Results informed by initial in vivo microbiome analysis of marijuana users and non-users with periodontitis. Antimicrobial peptoids were screened for activity against CBD-resistant bacteria.

What this study cannot tell us

In vitro susceptibility testing may not reflect conditions in the oral cavity. CBD concentrations achievable in saliva depend on consumption method. Microbiome analysis was preliminary and from a small sample. Peptoid treatments are experimental and not yet tested in vivo.

How to read the evidence

Well-designed in vitro study with both susceptibility testing and proof-of-concept therapeutic approach, but needs in vivo validation.

When this study was published

Published 2025.

The bigger picture

This is the first mechanistic explanation for cannabis-associated periodontitis that accounts for both the antibacterial properties of cannabinoids and the paradox of worsened oral disease. It also points toward a potential solution: antimicrobial peptoids that target the resistant bacteria could be developed as adjunctive treatments.

Questions still open

Whether different cannabis consumption methods (smoking vs. edibles) produce different oral microbiome effects
Whether antimicrobial peptoids could prevent or treat cannabis-associated periodontitis in clinical settings

Common questions

Does cannabis cause gum disease?

Cannabis use is associated with higher rates of periodontitis. This study suggests a mechanism: CBD selectively kills some oral bacteria while leaving disease-promoting resistant species to thrive, creating an imbalanced oral ecosystem that favors gum disease.

Does this mean CBD mouthwash would be harmful?

Potentially, yes. While CBD has antibacterial properties against some oral pathogens, its inability to kill resistant pathobionts like Treponema species means it could actually worsen oral health by creating dysbiosis rather than protecting against it.

Read the original research

Identification of cannabinoid-sensitive and -resistant oral bacteria.

Frontiers in microbiology, 16, 1709243

View on PubMed ↗Publisher’s paper ↗

Citation

Scott, David A; Lamont, Gwyneth J; Tan, Jinlian; Patel, Arjun P; Guffey, Jack T; Thomas, Scott C; Xu, Fangxi; Diamond, Gill; Saxena, Deepak. (2025). Identification of cannabinoid-sensitive and -resistant oral bacteria.. Frontiers in microbiology, 16, 1709243. https://doi.org/10.3389/fmicb.2025.1709243